Gruppo Italiano Malattie EMatologiche dell'Adulto: all 134 studies
Page 2 of 2. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.
- PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous ThromboembolismCompletedNCT01855698
- Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.CompletedNCT01791101Phase 2
- Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.CompletedNCT01762202Phase 2
- Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With DasatinibStatus unknownNCT01761890
- Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase InhibitorsStatus unknownNCT01752062
- Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic PhaseCompletedNCT01699217
- Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin DiseaseCompletedNCT01696474Phase 2
- Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) PatientsTerminatedNCT01570465
- Nilotinib in PH+, BCR-, ABL+ CML PatientsCompletedNCT01535391Phase 3
- Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)CompletedNCT01510873
- Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With NilotinibCompletedNCT01475110
- Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With ChemotherapyCompletedNCT01472107
- Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01452646Phase 2
- De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) PatientsStatus unknownNCT01361438Phase 2
- Patient Reported Outcomes in Chronic Myeloid LeukemiaCompletedNCT01252589
- Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic LeukemiaCompletedNCT01156883Not applicable
- Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01154439Phase 1
- AIDA 2000 GuidelinesStatus unknownNCT01064570Phase 2
- "AIDA" Protocol (LAP 0493)Status unknownNCT01064557Not applicable
- Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational StudyCompletedNCT01025505Phase 2
- Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line TherapyCompletedNCT00896129
- Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic SyndromesStatus unknownNCT00809575
- Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00769327Phase 2
- Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic PurpuraCompletedNCT00657410Phase 3
- DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AMLCompletedNCT00589082Phase 3
- Adult ALL Treatment at DiagnosisCompletedNCT00537550Not applicable
- Phase III Trial in Acute Promyelocytic Leukemia PatientsCompletedNCT00482833Phase 3
- Nilotinib as First-line Treatment of Ph+ CML in Early Chronic PhaseCompletedNCT00481052Phase 2
- "Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly PatientsCompletedNCT00475280Phase 2
- Safety, Tolerability, and Efficacy of Deferasirox in MDSCompletedNCT00469560Phase 3
- AML Treatment in Untreated Adult PatientsStatus unknownNCT00449319Not applicable
- Velcade in Myelodysplastic Syndrome - Pilot StudyTerminatedNCT00440076Phase 2
- GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.Status unknownNCT00439920Phase 2
- STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic LeukemiaCompletedNCT00376467Phase 2
← Gruppo Italiano Malattie EMatologiche dell'Adulto overview and focus areas